Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart

Keyphrases

• Protective Effect 100%
• Glucagon-like 100%
• Ischemia-reperfusion Injury 100%
• Exendin-4 (Ex-4) 100%
• Amides 100%
• Rat Heart 100%
• A1 Receptor 30%
• Exendin (9-39) 23%
• Postconditioning 15%
• Reperfusion 15%
• Receptor Antagonist 7%
• Plasma Glucose 7%
• Clinical Setting 7%
• Glucose-lowering Drugs 7%
• Left Ventricular Function 7%
• Infarct 7%
• Cardiovascular Effects 7%
• Incretin 7%
• Infarct Size 7%
• Receptor Targets 7%
• Diabetes Management 7%
• Ischemic Area 7%
• Intestinal L Cells 7%
• Endogenous Metabolites 7%
• Rate Pressure Product 7%
• Targeted Drugs 7%
• Liming Effect 7%
• Left Ventricular Developed Pressure 7%
• Isolated Rat Heart 7%
• Diabetic Hyperglycemia 7%
• Peptide Agonist 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Exendin 4 100%
• Glucagon-Like Peptide-1 100%
• Carboxamide 100%
• Reperfusion Injury 100%
• Glucagon-Like Peptide 1 Receptor 44%
• Exendin 9 33%
• Infarction 22%
• Receptor Antagonist 11%
• Diabetes Mellitus 11%
• Incretin 11%
• Hyperglycemia 11%
• Drug Delivery System 11%